《全日速報》恆指升359點; 恆生科技指數升108點 信義光能升逾7% 中生製藥、周大福、中創新航、三生製藥、康諾亞-B創新高 成交暢旺
恆指全日收25,417點,升359點或1.4%。恆生科技指數報5,687點,升108點或1.9%。國指升120點或1.3%,報9,057點。大市成交額2,999.45億元。
活躍重磅股表現:
騰訊(00700.HK) 收605.5元,上升2.2%;
美團(03690.HK) 收103元,上升1.6%;
阿里巴巴(09988.HK) 收131.8元,上升1.5%;
小米集團(01810.HK) 收53.65元,上升0.4%;
平安(02318.HK) 收55.45元,下跌0.4%;
異動恆指及國指成份股:
信義光能(00968.HK) 收3.71元,上升7.5%;
中生製藥(01177.HK) 收8.91元,上升6.2%,創新高;
恆隆地產(00101.HK) 收8.49元,上升6.1%;
紫金礦業(02899.HK) 收28.24元,上升5.8%;
中國宏橋(01378.HK) 收24.96元,上升5.1%;
中芯(00981.HK) 收58.7元,上升4.8%;
藥明生物(02269.HK) 收36.94元,上升4.7%;
信義玻璃(00868.HK) 收8.55元,上升4.7%;
翰森製藥(03692.HK) 收37.12元,上升4.6%;
快手-W(01024.HK) 收72.95元,上升4.4%;
藥明康德(02359.HK) 收113.6元,上升4.2%;
九龍倉置業(01997.HK) 收22.62元,上升3.9%;
美的集團(00300.HK) 收86.5元,上升3.8%;
聯想集團(00992.HK) 收11元,上升3.4%;
石藥(01093.HK) 收11.19元,上升3.3%;
周大福(01929.HK) 收16.02元,上升3%,創新高;
異動綜合中小型股:
中創新航(03931.HK) 收29.26元,上升18.4%,創新高;
三生製藥(01530.HK) 收35.66元,上升18.2%,創新高;
方舟健客(06086.HK) 收4.71元,上升14.9%;
康諾亞-B(02162.HK) 收78.45元,上升14.5%,創新高;
歐康維視生物-B(01477.HK) 收10.5元,上升13.4%;
天齊鋰業(09696.HK) 收44.56元,上升13.3%;
天能動力(00819.HK) 收8.54元,上升12.8%;
贛鋒鋰業(01772.HK) 收34.98元,上升12.5%;
協鑫科技(03800.HK) 收1.47元,上升12.2%;
晶泰控股(02228.HK) 收10.68元,上升12.2%;
信義能源(03868.HK) 收1.39元,上升10.3%;
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.